The Women's - The Royal Women's Hospital Victoria
homeour serviceshealth informationhealth professionalsour researchabout ussupport the women's
The Women's Home
Search The Womens' Website 

references: women's health nurse practitioner management prescription of oral contraceptives


References: Women's Health Nurse Practitioner Management Prescription of Oral Contraceptives

AMH 6th Ed. 2005. The Australian Medicines Handbook. Adelaide, Australian Medicines Handbook Pty Ltd.

Ashok, P., Stalder, C., Wagaarachchi, P., Flett, G., Melvin, L., Templeton, A. 2003. A randomised study comparing a low dose mifepristone and the Yupze regimen for emergency contraception. British Journal of Obstetrics and Gynaecology. 109(5):553-560.

Brown, K. 2000. Management Guidelines for Women's Health Nurse Practitioners. F.A. Davis Co, Philadelphia.

Cosmi, B., Legnani, C., Bernardi, F., Cocceri, S., Palareti, G. 2003. Role of family history in identifying women with thrombophilia and higher risk of thromboembolism during oral contraception. Archives of Internal Medicine. 163(9):1105-1109.

CP Medica Australia Pty Ltd. (2004) Mims Online. Viewed at: http://mims.hcn.net.au/ifmx-nsapi/mims-data/?MIval=2MIMS_ssearch on Feb 24th, 2005.

D'Souza, R., Guillebaud, J. 2002. Risks and benefits of oral contraceptive pills. Best Practice and Reasearch in Clinical Obstetrics and Gynaecology. 16(2):133-154.

Family Planning Victoria. 1995. Sexuality and the Law in Victoria, Fertility and Sexual Health. Family Planning Victoria. Richmond.

Family Planning Victoria. 2000. Women's Health Nurse Practitioner Clinical Practice Guidelines Professional Support Program - Two. Pap Screen Victoria, Anti-Cancer Council of Victoria.

Foidart, J., Wuttke, W., Bouw, G., Gerlinger, C., Heithecker, R. 2000. A comparitive investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel. European Journal of Contraception & Reproductive health care. 5(2):124-34.

Gilbert, A. 2002. I've missed a dose; what should I do? Australian Prescriber 25:16-18.

Gold, M. 1999. Prescribing and managing oral contraceptive pills and emergency contraception for adolescents. Paediatric Clinics of North America. 46:695-718.

Heinmann LA. Dinger J. 2004. Safety of a new oral contraceptive containing drospirenone. Drug Safety 27(13):1001-18

Henderson, L., Yue, Q., Bergquist, C., Arlett, P. 2002. St John's Wort (Hypericum perforatum): drug interactions and clinical outcomes. British Journal of Clinical Pharmacology. 54(4):349-356.

Holt, V., Scholes, D., Wicklund, K., Cushing-Haugen, K. & Daling, J. 2005. Body Mass Index, Weight and Oral Contraceptive Failure Risk Obstetrics & Gynaecology 10591): 46-52. January.

International Planned Parenthood Federation. 2003. Routine breast and pelvic examination before prescription of hormonal contraception. IPPF Medical Bulletin. 37(1).

International Planned Parenthood Federation. 2002. IMAP statement on hormonal methods of contraception. IPPF Medical Bulletin. 36(5).

McNamee, K., & Williams, H. 2002. Family Planning Victoria Guidelines for Clinical Practice, edition 1. FPA Health, NSW. Department of Human Services.

Medical Practitioners Board of Victoria. 2004. Minor's Right to Consent to Medical Treatment. Information for Doctors. Victoria.

National Health and Medical Research Council (NHMRC). 1999. A Guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines. Australian Government Publishing Service, Canberra.

National Health and Medical Research Council (NHMRC). 2003. Human Research Ethics Handbook. Australian Government Publishing Service, Canberra.

The Royal Women's Hospital. 2003. RWH Medication Prescribing Guidelines. Carlton, Vic.

Sulak, P. Creative use of oral contraceptives in the perimenopausal patient. 2003. In: Santoro, N & Goldstein, S. Textbook of Perimenopausal Gynaecology. The Parthenon Publishing Group, New York.

State of Victoria. 2004. Therapeutic Guidelines: Endocrinology Version 3. Therapeutic Guidelines Ltd, Nth Melbourne.

Vandenbrouke, J., Van der Meer, F., Helmerhorst, F., Rosendaal, F. 1996. Factor V Leiden: should we screen oral contraceptive users and pregnant women? British Medical Journal.313(7065):1127-1130.

Walker, G., Schlessman, J, Ness, R. 2002. Family history of cancer, oral contraceptive use, and ovarian cancer risk. American Journal of Obstetrics and Gynaecology. 186(1):8-14.

Weisberg, E. 2002. Contraception, hormone replacement therapy and thrombosis. Australian Prescriber (25): 57-9.

Weisberg, E. 1999. Progesterone-only methods of contraception. Australian Prescriber (22):6-8.

World Health Organization. 2003. Improving Access to Quality Care in Family Planning. Medical Eligibility Criteria for Contraceptive Use, 2nd Edition.


Royal Women's Hospital Clinical Practice Guidelines (CPGs) are intended to provide guidance to health care professionals, based on a thorough evaluation of research evidence, on the practical assessment and management of specific clinical issues or situations. The guidelines allow some flexibility on the part of the health care professional based on the needs of the specific patient for whom they are caring.

Please remember to read our disclaimer.

Powered by Komodo CMS